Concepedia

Jorge A. Tavel

JA

34

Publications

1.5K

Citations

21

H-Index

2000

Active since

Affiliations

National Institutes of Health(Current)

National Institute of Allergy and Infectious Diseases

University of Minnesota

Science Applications International Corporation (United States)

National Institutes of Health Clinical Center

Jorge A. Tavel is an author at National Institutes of Health specializing in medicine, hiv, and immunology.

Top concepts

Publications per year

2000–2021

34

Publications

34

Identification of Dynamically Distinct Subpopulations of T Lymphocytes That Are Differentially Affected by HIV

Joseph A. Kovacs, Richard A. Lempicki, Igor A. Sidorov et al. · The Journal of Experimental Medicine · 2001 · 221 citations · Full text

Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients

Joseph A. Kovacs, Richard A. Lempicki, Igor A. Sidorov et al. · Journal of Clinical Investigation · 2005 · 123 citations · Full text

, , +21

Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease

Lotty Ledwaba, Jorge A. Tavel, Paul Khabo et al. · PLoS ONE · 2012 · 98 citations · Full text

A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti- <i>Staphylococcus aureus</i> Thiomab Antibody-Antibiotic Conjugate, in Healthy Volunteers

Melicent C. Peck, Michael E. Rothenberg, Rong Deng et al. · Antimicrobial Agents and Chemotherapy · 2019 · 98 citations · Full text

Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients

Julie H. Ishida, Anita Patel, Aneesh K. Mehta et al. · Antimicrobial Agents and Chemotherapy · 2016 · 94 citations · Full text

Rows per page

1–5 of 34